Recombinant anticancer vaccines.
Restifo
N P
NP
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
D000818:Animals; D019496:Cancer Vaccines; D002986:Clinical Trials as Topic; D005822:Genetic Vectors / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000517:prevention & control*; D014614:Vaccines, Synthetic; D014780:Viruses
D019496:Cancer Vaccines; D014614:Vaccines, Synthetic